Skip to main content
. 2020 Nov 24;12(12):3492. doi: 10.3390/cancers12123492

Table 2.

Alteration incidences of the driver genes.

Genes Incidence Reported Incidence p-Value
EGFR 24.0% (187/780) 26.0% (1491/5738) [5] p = 0.2282
Exon 19 deletion 55.1% (103/187) 47.1% (702/1491) [5] p = 0.0391 †
Exon 21 L858R 31.0% (58/187) 37.3% (556/1491) [5] p = 0. 0931
Exon 20 S768I 1.6% (3/187) 3.1% (12/382) [7] p = 0.2824
T790M 0.5% (4/780) 1.4% (85/5738) [5] p = 0.0268 †
Others 10.2% (19/187) N/A N/A
KRAS 18.7% (77/411) 14.0% (190/1355) [5] p = 0.0195 †
ALK 3.9% (28/710) 4.2–10.5% [8] N/A
ROS1 2.2% (7/322) 0.7–3.4% [15] N/A
RET 2.1% (4/190) 1.0–3.0% [16] N/A
MET (Amplification) 10.2% (18/172) 2–20% [2,16,17,18] N/A
BRAF 4.3% (4/94) 1–5% [19] N/A
ERBB2 5.8% (4/69) 2–5% [20] N/A

p < 0.05.